Literature DB >> 22330687

Urological cancer: Are we redeemed from aggressive treatment for prostate cancer?

M Teresa Villanueva.   

Abstract

Entities:  

Year:  2012        PMID： 22330687     DOI： 10.1038/nrclinonc.2012.10

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

Authors:  Neil E Fleshner; M Scott Lucia; Blair Egerdie; Lorne Aaron; Gregg Eure; Indrani Nandy; Libby Black; Roger S Rittmaster
Journal:  Lancet       Date:  2012-01-24       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.